Progesterone to help prevent early delivery after IVF
Part of Women’s health & pregnancy clinical trials.
This trial tests whether taking progesterone for longer during an IVF pregnancy can help lower the risk of preterm birth (birth too early). It is for people who are pregnant from a fresh embryo transfer of a single embryo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 40 years old.
- You are pregnant (or will be) from IVF using a fresh embryo transfer (not frozen).
- Your pregnancy is expected to be a singleton (one baby), not twins or more.
- You do not have a history of late pregnancy miscarriage (in the second trimester) or a weak cervix (cervical insufficiency).
- You have no major uterine or cervix problems (such as abnormal shape) or past cervical surgery.
- You can join follow-up for the full study and are willing to sign informed consent. (Also, you generally can’t join another study in the last 90 days or use another investigational drug in the last 30 days.)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a cervical stitch (cerclage) to progesterone treatment helps prevent early birth better than progesterone alone in women with a short cervix.
This study looks at different care pathways to help lower the risk of preterm birth (birth too early). It will follow pregnant people with a singleton pregnancy to see which approaches may work best for preventing early delivery.
This trial tests whether giving extra progesterone injections after an embryo transfer can improve pregnancy outcomes for women who have low progesterone levels. It may help support the pregnancy in its early stages.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This study tests how hormone levels (progesterone) change day to day in the lining of the uterus (endometrium) during an embryo transfer in a medicated cycle. The goal is to better time the transfer and improve success rates.
This study looks at whether the level of progesterone, a hormone that helps prepare the uterus for pregnancy, on the day of embryo transfer affects the chance of a successful pregnancy in women using frozen embryos. It may help doctors understand if adjusting progesterone could improve outcomes.
Hear when a new Preterm Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.